Home » Stocks » ATRI

Atrion Corporation (ATRI)

Stock Price: $613.21 USD 4.21 (0.69%)
Updated December 2, 10:44 AM EST - Market open

Stock Price Chart

Key Info

Market Cap 1.12B
Revenue (ttm) 149.81M
Net Income (ttm) 32.81M
Shares Out 1.83M
EPS (ttm) 17.75
PE Ratio 34.55
Forward PE n/a
Dividend $7.00
Dividend Yield 1.14%

Stock Quote

Trading Day December 2
Last Price $613.21
Previous Close $609.00
Change ($) 4.21
Change (%) 0.69%
Day's Open 604.78
Day's Range 613.10 - 613.21
Day's Volume 753
52-Week Range 574.90 - 749.47

More Stats

Market Cap 1.12B
Enterprise Value 1.08B
Earnings Date (est) n/a
Ex-Dividend Date Nov 30, 2020
Shares Outstanding 1.83M
Float n/a
EPS (basic) 17.79
EPS (diluted) 17.75
FCF / Share 8.17
Dividend $7.00
Dividend Yield 1.14%
Earnings Yield 2.89%
FCF Yield 1.33%
Payout Ratio 36.00%
Shares Short 51,935
Short Ratio 7.12
Short % of Float n/a
Beta 0.16
PE Ratio 34.55
Forward PE n/a
P/FCF Ratio 75.05
PS Ratio 7.49
PB Ratio 5.25
Revenue 149.81M
Operating Income 37.42M
Net Income 32.81M
Free Cash Flow 14.94M
Net Cash 42.78M
Net Cash / Share 23.39
Gross Margin 47.18%
Operating Margin 24.98%
Profit Margin 21.90%
FCF Margin 9.97%
ROA 9.00%
ROE 13.95%
ROIC 19.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$300.00*
Low
300
Current: $613.21
High
300
Target: 300.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue155152147143146141132119118109
Revenue Growth1.72%3.99%2.17%-1.54%3.53%6.64%10.86%1.15%8.41%-
Gross Profit70.6971.7870.7567.6370.9868.5263.0656.1460.0150.91
Operating Income40.5341.7141.2739.1342.5140.8237.9433.6338.1730.98
Net Income36.7634.2636.5927.5828.9327.8126.5823.6326.0420.95
Shares Outstanding1.861.851.851.821.851.962.012.022.022.02
Earnings Per Share19.7318.4419.7114.8515.4714.0813.1811.6612.8210.32
EPS Growth7%-6.44%32.73%-4.01%9.87%6.83%13.04%-9.05%24.22%-
Dividend Per Share5.805.104.503.903.302.782.4012.101.8210.56
Dividend Growth13.73%13.33%15.38%18.18%18.71%15.83%-80.17%564.84%-82.77%-
Operating Cash Flow42.4743.2447.0437.4040.4331.2236.5829.3731.5431.06
Capital Expenditures-20.45-17.51-9.68-10.64-9.32-12.67-7.50-10.35-12.00-4.29
Free Cash Flow22.0225.7337.3626.7631.1018.5529.0719.0219.5426.77
Cash & Equivalents68.8168.4465.6044.1028.3923.8646.9116.1844.8721.39
Net Cash / Debt68.8168.4465.6044.1028.3923.8646.9116.1844.8721.39
Assets262231204182164172172156162135
Liabilities24.1620.4519.3918.9520.2421.9423.0720.9823.3818.04
Book Value238211184163144150149135139117
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Atrion Corporation
Employees 616

Stock Information

Ticker Symbol ATRI
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Unique Identifier NASDAQ: ATRI

Description

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.